Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$85.07 - $94.48 $352,615 - $391,619
4,145 New
4,145 $366,000
Q1 2020

May 15, 2020

SELL
$71.37 - $96.85 $884,773 - $1.2 Million
-12,397 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$64.27 - $86.37 $2.78 Million - $3.74 Million
-43,306 Reduced 77.74%
12,397 $1.05 Million
Q3 2019

Nov 14, 2019

SELL
$67.4 - $85.11 $647,107 - $817,141
-9,601 Reduced 14.7%
55,703 $3.75 Million
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $5.25 Million - $6.13 Million
65,304 New
65,304 $5.59 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.